NCT06033859

Brief Summary

The primary goal of the present prospective cohort study is to evaluate the effect of varying incidences of BOP at implant sites across 15 months of maintenance visits on the probability of peri-implant disease progression. Over 15 months, participants will attend 6 visits where clinical measurements and maintenance care will be performed every 3 months.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
19mo left

Started Sep 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Sep 2023Dec 2027

First Submitted

Initial submission to the registry

September 5, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

September 11, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

October 10, 2025

Status Verified

October 1, 2025

Enrollment Period

4.2 years

First QC Date

September 5, 2023

Last Update Submit

October 8, 2025

Conditions

Keywords

Bleeding on probingPeri-implant mucositis

Outcome Measures

Primary Outcomes (1)

  • Marginal Bone Loss (MBL)

    MBL will be calculated by measuring the difference in marginal bone level between the standardized periapical radiographs. Progression will have to exceed a threshold of 0.5mm to be considered.

    Baseline and 15 months

Secondary Outcomes (3)

  • Incidence of BOP

    3, 6, 9, 12 and 15 months

  • Changes in probing depth (PD)

    Baseline, 3, 6, 9, 12 and 15 months

  • Mucosal recession

    Baseline, 3, 6, 9, 12 and 15 months

Other Outcomes (1)

  • Peri-implant mucosal phenotype

    Baseline and 15 months

Study Arms (4)

Implants with BOP score 0

Implants with no BOP according to the modified bleeding index at baseline.

Diagnostic Test: Clinical measurementsDiagnostic Test: Radiographic measurementProcedure: Dental prophylaxis or maintenance

Implants with BOP score 1

Implants with a bleeding dot at baseline.

Diagnostic Test: Clinical measurementsDiagnostic Test: Radiographic measurementProcedure: Dental prophylaxis or maintenance

Implants with BOP score 2

Implants with a continuous line of blood that fills the sulcus at baseline.

Diagnostic Test: Clinical measurementsDiagnostic Test: Radiographic measurementProcedure: Dental prophylaxis or maintenance

Implants with BOP score 3

Implants with a profuse bleeding and/or hemorrhage drip at baseline.

Diagnostic Test: Clinical measurementsDiagnostic Test: Radiographic measurementProcedure: Dental prophylaxis or maintenance

Interventions

Clinical measurementsDIAGNOSTIC_TEST

With the aid of a periodontal probe, the incidence of BOP, as well as PD, recession and KM will be assessed.

Implants with BOP score 0Implants with BOP score 1Implants with BOP score 2Implants with BOP score 3

A standardized periapical radiograph of the implant will be completed at the beginning and the end of study to determine the marginal bone loss.

Implants with BOP score 0Implants with BOP score 1Implants with BOP score 2Implants with BOP score 3

Dental prophylaxis or maintenance will be performed every 3 months.

Implants with BOP score 0Implants with BOP score 1Implants with BOP score 2Implants with BOP score 3

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The population from which cases will be recruited are from the patients of record at the University of Pittsburgh Periodontics Department who meet the inclusion criteria of the study.

You may qualify if:

  • adults in good general health (at least ASA 2)
  • having ≥ 1 dental implant that was restored before January 2021
  • patients of the University of Pittsburgh Periodontics Department
  • available for maintenance visits every 3 months for the length of the study

You may not qualify if:

  • Active infectious diseases of any kind
  • Pregnant or planning to become pregnant (self-reported)
  • Congenital or metabolic bone disorders
  • Current heavy smokers: Subjects who have smoked more than 1 pack/day within 6 months of study onset
  • Co-morbid conditions that would affect the study outcome or interpretation of study results
  • Require treatment for periodontal disease prior to baseline

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh School of Dental Medicine

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Peri-Implantitis

Interventions

Dental ProphylaxisMaintenance

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

PeriodonticsDentistryPreventive DentistryHealth Care Facilities Workforce and Services

Study Officials

  • Andrea Ravida, DDS MS

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 5, 2023

First Posted

September 13, 2023

Study Start

September 11, 2023

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

October 10, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations